SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
1-Year Return
0.41%
This Quarter Return
-5.65%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$417M
AUM Growth
-$49.9M
(-11%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
95
New
14
Increased
25
Reduced
19
Closed
15
Top Buys
| 1 |
Tower Semiconductor
TSEM
|
$7.42M |
| 2 |
Cytokinetics
CYTK
|
$6.89M |
| 3 |
Advanced Micro Devices
AMD
|
$4.97M |
| 4 |
Meta Platforms (Facebook)
META
|
$4.57M |
| 5 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$3.79M |
Top Sells
| 1 |
Nice
NICE
|
$8.5M |
| 2 |
Nova
NVMI
|
$8.21M |
| 3 |
Camtek
CAMT
|
$6.75M |
| 4 |
Praxis Precision Medicines
PRAX
|
$6.69M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
$6.02M |
Sector Composition
| 1 | Healthcare | 79.93% |
| 2 | Technology | 10.32% |
| 3 | Consumer Discretionary | 2.91% |
| 4 | Communication Services | 1.1% |
| 5 | Materials | 0.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Replimune Group
REPL
$453M
| $3.17M | 0.58% |
+185,016
| New | +$3.17M |
|
52
Gilead Sciences
GILD
$140B
| $3M | 0.55% |
40,000
| – | – |
|
53
Pfizer
PFE
$139B
| $2.99M | 0.54% |
90,000
-50,000
| -36% | -$1.66M |
|
54
Pliant Therapeutics
PLRX
$100M
| $2.71M | 0.49% |
+156,134
| New | +$2.71M |
|
55
ICL Group
ICL
$7.85B
| $2.61M | 0.48% |
+470,000
| New | +$2.61M |
|
56
CrowdStrike
CRWD
$104B
| $2.51M | 0.46% |
+15,000
| New | +$2.51M |
|
57
Kezar Life Sciences
KZR
$27.9M
| $2.44M | 0.44% |
205,168
+6,345
| +3% | +$75.5K |
|
|
MORF
58
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $2.06M | 0.38% |
90,000
| – | – |
|
|
ALPN
59
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $2.06M | 0.38% |
180,000
-20,000
| -10% | -$229K |
|
60
Gossamer Bio
GOSS
$573M
| $1.61M | 0.29% |
+1,932,568
| New | +$1.61M |
|
61
Vera Therapeutics
VERA
$1.4B
| $1.44M | 0.26% |
105,000
| – | – |
|
62
Werewolf Therapeutics
HOWL
$61.7M
| $1.34M | 0.24% |
626,810
| – | – |
|
63
Xenon Pharmaceuticals
XENE
$2.98B
| $1.33M | 0.24% |
+38,959
| New | +$1.33M |
|
64
Rigel Pharmaceuticals
RIGL
$721M
| $1.33M | 0.24% |
122,813
| – | – |
|
65
Rezolute
RZLT
$642M
| $1.32M | 0.24% |
996,710
-159,187
| -14% | -$210K |
|
66
Compugen
CGEN
$133M
| $1.23M | 0.22% |
1,319,239
+89,431
| +7% | +$83.2K |
|
67
MediWound
MDWD
$182M
| $1.15M | 0.21% |
108,533
-2,594
| -2% | -$27.6K |
|
68
uniQure
QURE
$975M
| $998K | 0.18% |
148,734
| – | – |
|
69
Cartesian Therapeutics
RNAC
$262M
| $797K | 0.15% |
25,071
-42,879
| -63% | -$1.36M |
|
70
Apogee Therapeutics
APGE
$2.21B
| $639K | 0.12% |
+30,000
| New | +$639K |
|
|
ELEV
71
DELISTED
Elevation Oncology
ELEV
| $596K | 0.11% |
900,000
| – | – |
|
72
VistaGen Therapeutics
VTGN
$111M
| $524K | 0.1% |
+100,000
| New | +$524K |
|
|
IMTXW
73
DELISTED
Immatics N.V. Warrants
IMTXW
| $354K | 0.06% |
100,000
| – | – |
|
|
CALT
74
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $217K | 0.04% |
+11,863
| New | +$217K |
|
75
Arcellx
ACLX
$4B
| – | – |
-77,488
| Closed | -$2.45M |
|